Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (23819)	8/3/1998 1:24:00 PM
From: tonyt	Read Replies (1) \| Respond to of 32384

"Only the bzshadow knows" btw, why don't you use your real name on AOL?

To: bob zagorin who wrote (23819)	8/3/1998 1:36:00 PM
From: tonyt	Respond to of 32384

BOSTON--(BW HealthWire)--Aug. 3, 1998--An in-depth look at companies, stocks and industry sectors that will grow in importance in the 21st Century will be the focus at the First Informed Investors Boston Biotechnology Stocks Forum Tuesday, Sept. 15 at the Back Bay Hilton. The Forum runs from 8:30 a.m.-4 p.m. "We are excited about bringing our popular Informed Investors Forum format to Boston, after New York probably America's most important financial center," said Tim Quast, vice president and chief operating officer of Informed Investors, Inc. of Sacramento, Calif. "For five years, we have been leveling the playing field for individual investors, giving them access to executives of public companies and leading industry authorities just as institutional investors and analysts receive. Moreover, we have developed a particular expertise in biotechnology and technology, both important industries in Boston. "The Boston Forum will follow one we are currently developing for Saturday, Sept. 12 in New York," Quast added. "It will be held at a hotel in the Meadowlands area just across from Manhattan. That will be an eight-company biopharma forum." In Boston, two prominent biotech analysts, Meg Malloy of Hambrecht & Quist and Eric Schmidt, Ph.D of Cowen & Co., will give current insight and perspective on the rapidly-growing and fast-changing biotech industry. The cost to attend is $40 prepaid, $55 at the door. Call Informed Investors at 800/992-4683 to register. Audio tapes will be available for investors unable to attend. The full set (seven cassettes) is $50 plus $4.95 S/H which includes all company presentations plus keynote speakers. Individual tapes are $18. Transcripts of Malloy's and Schmidt's comments are $25. Access Informed Investors' website at informedinvestors.com for more information and updates. In addition to Malloy and Schmidt, executives from 12 biotechnology companies will give 20-25 minute presentations, followed by Q&A, which replicate the format common at industry investment banking conferences that are typically closed to individual investors. The presenting companies are: Biogen (NASDAQ:BGEN); Biosource International (NASDAQ:BIOI); Boston Life Sciences (NASDAQ:BLSI); Creative BioMolecules (NASDAQ:CBMI); Genzyme Tissue Repair (NASDAQ:GENL); Genzyme Transgenics (NASDAQ:GZTC); Ilex Oncology (NASDAQ:ILXO); Integra LifeSciences (NASDAQ:IART); Ligand Pharmaceuticals (NASDAQ:LGND); Repligen (NASDAQ:RGEN); T Cell Sciences (NASDAQ:TCEL) and XOMA Corp. (NASDAQ:XOMA). The Boston Forum is one in a succession of biotech/medtech forums sponsored by Informed Investors. Audio tapes are available for all Forums. On Aug. 1, the following biotech/medtech companies presented at the San Diego Biomedical Forum: Alliance Pharmaceutical (NASDAQ:ALLP); La Jolla Pharmaceutical (NASDAQ:LJPC); Cytel Corp. (NASDAQ:CYTL); Isis Pharmaceuticals (NASDAQ:ISIP) Avigen (NASDAQ:AVGN); Genentech (NYSE:GNE); Inhale Therapeutics (NASDAQ:INHL); Cardima (NASDAQ:CRDM); Medical Science Systems (NASDAQ:MSSI); Zevex International (AMEX:ZVX); VISX, Inc. (NASDAQ:VISX); SteriGenics International (NASDAQ:STER); and BioSource International. Keynote speakers are Jim McCamant, Editor of the Medical Technology Stock Letter (www.bioinvest.com) and Dr. Alex Arrow, Vice President/Research at Wedbush Morgan Securities in Los Angeles, and Michael Yellen, portfolio manager of the AIM Global Health Care Funds (NASDAQ:GGHCX). On June 6 at the Beltway Biotech Forum in Bethesda, Md., presenting companies were: EntreMed Inc. (NASDAQ:ENMD); CytRx (NASDAQ:CYTR); Gene Logic (NASDAQ:GLGC); Integra LifeSciences, SunPharm (NASDAQ:SUNP); Boston Life Sciences and OSI Pharmaceuticals (NASDAQ:OSIP). The keynote speakers were Kris Jenner, M.D., Ph.D., BioPharma Analyst at T. Rowe Price Associates (NASDAQ:TROW) of Baltimore, and Dr. Alex Arrow. On July 26 at the Fifth Bay Area Biotech Stocks Forum in San Francisco, presenting companies were: Megabios Corp. (NASDAQ:MBIO); Protein Design Labs (NASDAQ:PDLI); Sequus (NASDAQ:SEQU); Shaman Pharmaceuticals (NASDAQ:SHMN); Sugen (NASDAQ:SUGN); SunPharm and SangStat Pharmaceuticals (NASDAQ:SANG). Keynote speakers Peter Freudenthal, senior biotech analyst for BA Robertson Stephens, and Kurt von Emster, portfolio manager for the Franklin Strategic Biotechnology Fund (NASDAQ:FBDIX). Their presentations gave a thorough overview of the industry and prospects for many companies. Since 1993, Informed Investors has featured scores of quality companies and industry experts at its Forums. Informed Investors represents individual investors who collectively hold an estimated $2 billion in investable assets. CONTACT: Informed Investors, Inc. Steve Chanecka or Sean Finnigan, 916/448-8222 or 800/992-4683 KEYWORD: MASSACHUSETTS CALIFORNIA INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICINE BANKING TRADESHOW Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com Copyright 1998, Business Wire